For external use only. Apply a small amount of gel to the affected area and rub it gently until it is absorbed. Wash hands thoroughly after application.

Flurbiprofen inhibits prostaglandin synthesis by reversibly inhibiting cyclooxygenase (COX-1 and COX-2) enzymes. This reduces the formation of inflammatory mediators, thereby decreasing pain, inflammation, and swelling at the site of application.

• •Hypersensitivity to flurbiprofen or other NSAIDs, including aspirin
• •Patients with asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs
• •Third trimester of pregnancy
• •Application to open wounds, infected skin, eczema, or mucous membranes

Store below 30°C in a dry place, away from direct sunlight. Do not freeze. Keep out of reach of children.

Overdose with topical application is unlikely due to minimal systemic absorption. In case of accidental ingestion or excessive application, symptomatic and supportive measures should be taken. Gastric decontamination may be considered if ingested.

Avoid during the third trimester of pregnancy. Use during the first two trimesters and during lactation only if clearly necessary and potential benefits outweigh risks, under medical supervision, due to limited systemic absorption.